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Abstract The theme of ISOQOL’s 19th Annual Confer-
ence in Budapest, Hungary, was The Journey of Quality of
Life Research: A Path Towards Personalized Medicine.
Innovations in e-health was one of four plenary panels.
E-health is changing the landscape of clinical practice and
health care, but the best way to leverage the many promised
benefits of emerging e-health technologies is still not clear.
The Innovations in e-health panel presented emerging
changes in technologies and applications that will facilitate
clinical decision making, improve quality and efficiency of
care, engage individuals in clinical decision making, and
empower them to adopt healthy behaviors. The purpose of
this paper was to present emerging trends in e-health and
considerations for successful adoption of new technologies,
and an overview of each of the presentations in the e-health
plenary. The presentations included a personal perspective
on the use of technology for self-monitoring in Parkinson’s
disease, an overview of online social networks and emer-
ging technologies, and the collection of patient-reported
outcomes through web-based systems in clinical practice.
The common thread across all the talks was the application
of e-health tools to empower individuals with chronic dis-
ease to be actively engaged in the management of their
health. Considerations regarding data ownership and pri-
vacy, universal access to e-health, interactivity between
different types of e-health technologies, and tailoring
applications to individual needs were explored.
Keywords E-health  Social network  Internet  Clinical
practice  Patient-reported outcome
Introduction
The theme of ISOQOL’s 19th Annual Conference in Buda-
pest, Hungary, was The Journey of Quality of Life Research: A
Path Towards Personalized Medicine. Innovations in e-health
was one of four plenary panels. E-health is changing the
landscape of health care and refers to ‘‘an emerging field in the
intersection of medical informatics, public health and busi-
ness, referring to health services and information delivered or
enhanced through the Internet and related technologies’’[1].
The best way to leverage emerging technologies to improve
quality of life is still not clear, though pockets of implemen-
tation [2] and early successes have been promising [3].
Actively engaging clinicians and patients’ in the design and
iteration of these new technologies will be a key in ensuring
widespread adoption. Continuous evaluation will be needed to
quantify their impact on quality of care, individuals’ health
and quality of life, and the reduction in healthcare costs.
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The growing fiscal and social burden of managing and
preventing chronic diseases remains one of the greatest
challenges facing healthcare systems worldwide [4], and
e-health can help meet this challenge in three key ways. The
first is increasing efficiency in health care, thereby decreas-
ing costs. This might be through avoiding duplication of
unnecessary diagnostic or therapeutic interventions, through
enhanced communication that enables care to have a wider
reach [5], or through off-loading of burdensome but simple
tasks to technology. Improving efficiency does not need to
come at the expense of the second area, enhancing the quality
of health care. For example, e-health may improve quality of
care by maintaining contact with patients between clinical
visits, allowing comparisons between different providers,
and incorporating patient reports of health and satisfaction
into quality assurance for payers and commissioners, as well
as other patients.
The third area of opportunity is empowering individuals
to actively manage their health and to adopt healthy
behaviors. e-health technologies such as personal health
records provide an opportunity for (1) ongoing disease
monitoring and feedback from the care team [6]; (2) pro-
viding enhanced self-management interventions and case
management when problems are identified [7]; and (3)
sharing of clinical information and treatment goals with the
patient. In this way, it is hoped that e-health could open
new avenues for patient-centered medicine, and eventually
enable evidence-based patient choice.
Patients are leading changes in the way they manage their
health through peer-to-peer support networks such as
PatientsLikeMe. Online networks enable patients to share
and compare and contrast different diagnoses and treatments
with people who have the same conditions who are any-
where in the world. Members of the online community can
ask for advice, learn from each other, discuss test results,
and compare how different medications, treatments, or
combinations of drugs might or might not be working [8].
This sharing of information creates a more informed and
empowered patient and can lead to a radical reconfiguring of
the patient/care team relationship. As health professionals
are no longer the only source of information, the relationship
becomes more equal and collaborative.
Along with their potential, however, e-health technolo-
gies might also carry some risks. For instance, some among
the medical community express concerns regarding the
quality of the information accessed online, as well as
patients’ health literacy and their ability to understand such
information [9]. Some studies suggest a shift of trust from
physicians’ advice to online and peer-to-peer sources,
especially among patients dissatisfied with their medical
provider. It remains unclear what the consequences might
be however; the only systematic review of harms inflicted
by the Internet was conducted in 2002 and found only a
single death [10–12]. Research regarding the impact of
e-health and potential risks of emerging technologies is
therefore scarce, and future studies will need to rigorously
address questions related to potential harms of e-health.
The Innovations in e-health panel presented emerging
changes in technologies and applications that will facilitate
clinical decision making, improve quality and efficiency of
care, engage individuals in clinical decision making, and
empower them to adopt healthy behaviors. The presenters
also addressed potential limitation of existing systems and
risks associated with e-health applications. Particular focus
was paid to applications supported by smart phones,
monitoring devices, and collection of patient-reported
outcomes (PROs) through web-based systems, including
online self-reporting and monitoring of symptoms and
health. Plenary speakers in this session shared their
expertise and innovative projects on topics that cover each
of these areas. This paper presents an overview of each of
these presentations.
Personal narrative: self-monitoring in Parkinson’s
disease, Jon Stamford
E-health, with its emphasis on shared decision making and
personal responsibility, is particularly well suited to use
with chronic illnesses where patterns of health change may
be both gradual and subtle. Small, slow improvements or
declines in health, while largely imperceptible from day to
day, can be readily unmasked by long-term monitoring.
Parkinson’s disease, a progressively neurodegenerative
disorder of variable chronology [13], where periods of
apparent stasis can be punctuated by stepwise increments
in symptomatology, sits well within the scope of e-health.
A typical clinical course with Parkinson’s disease may run
for more than 20 years with appropriate management.
Diagnosis of Parkinson’s disease is usually made on the
basis of three or four key motor symptoms—tremor, bra-
dykinesia, rigidity, and postural instability—although the
symptomatology of Parkinson’s disease also encompasses
many non-motor symptoms. These non-motor symptoms
include depression, anxiety, pain, constipation, anosmia,
and sleep disorders among many others. Often these non-
motor symptoms predate the clinical diagnosis of Parkin-
son’s disease, sometimes by as much as a decade. There is
good evidence as well that non-motor symptoms play at
least as large a part as motor symptoms in determining
individuals’ quality of life [14].
Polls by Parkinson’s Movement have shown that, for
patients, motor symptoms are a rather poor indicator of
quality of life (Fig. 1a) and that non-motor symptoms are a
major additional contributor (Fig. 1b). As with the motor
symptoms, there is extreme variability in the numbers and
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extent of non-motor symptoms experienced by patients,
presenting challenges for both treatment and assessment.
Parkinson’s disease presents a significant treatment
challenge to neurologists for a number of reasons. Firstly,
in seeing a patient only every several months, the resultant
clinical picture is little more than a snapshot of a patient
who may have overmedicated simply in order to make it to
the clinic for assessment. Secondly, post hoc questionnaires
of symptoms rely on accurate recollection by the patient
and, in any case, are inevitably biased toward more recent
events [15]. Thirdly, Parkinson’s disease has a highly
variable clinical presentation. No two patients are alike in
their combination of symptoms, making a ‘‘one size fits
all’’ treatment algorithm unfeasible. Fourthly, even in the
same patient, the day-to-day variability of the condition
makes treatment generalization challenging [16]. Fifthly,
clinical assessment of Parkinson’s disease seems histori-
cally to focus on motor symptoms. The importance of non-
motor symptoms is only recently acknowledged. Sixthly,
the health of most patients is dependent on compliance
with a rigid medication schedule. Collectively, these con-
siderations mean that treatment and assessment of Parkin-
son’s patients are highly individualized.
A positive response among the Parkinson’s community
to this disheartening symptomatic individuality has been to
take a strong personal interest in symptomatology and its
relation to well-being. In consequence, a number of means
of self-assessment have emerged. These range from simple
charts and diaries to full-blown computer-based applica-
tions. While the former have the advantage of simplicity
(and can be used in a power cut), the latter offers greater
scope for data management and trend analysis. The ability
to enter individual data into a centralized database offers
the opportunity to contextualize one’s own patient experi-
ence. This is in many respects the model upon which
PatientsLikeMe is predicated and which has proven
engaging for so many.
However, ultimately neither personalized health diary
nor large centralized database offers the perfect solution.
Both scientists and patients have been increasingly
engaged by the advent of wearable monitoring devices and
the scope offered by these [17]. Of course for many
patients, the most familiar ‘‘wearable’’ device is the mobile
phone. Modern smart phones with gyroscopes, acceler-
ometers, and processing power comparable to desktop
computers have spawned a multitude of ‘‘apps’’ that, while
not explicitly designed for use by Parkinson’s patients,
have nonetheless proved popular. Among these are apps to
measure reaction time, repetitive finger tapping, coordi-
nated movement, and exercise parameters. Seismographic
programs, although designed for earthquake detection,
work extraordinarily well when used to record and quantify
Parkinsonian tremor.
Although each of these applications has found favor
among patients, they fall short of the ideal in four ways.
Firstly, they address merely the motor symptoms of Par-
kinson’s disease. Secondly, they are not optimized specif-
ically for the purposes for which they are being used.
Thirdly, they lack the degree of interactivity and commu-
nity, which adds value to their usage. Fourthly, and
Fig. 1 a Variability of quality
of life in Parkinson’s patients.
The percentage of patients
categorized according to their
relationship between quality of
life and motor symptoms.
b Prevalence of motor and non-
motor symptoms reported to
contribute to the quality of life.
Data from 283 patients replying
to a Parkinson’s Movement poll
(October 2012)
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unsurprisingly, they lack the facility to give the patient
reminders about taking their dose of anti-Parkinsonian
medication, for instance.
The four considerations above are at least partially
addressed by apps such as PD Life [18]. This app, although
admirable in many ways, does not explicitly address motor
symptoms (although these may be added). Apps are
urgently required that combine physical measures of health
with motor symptoms and patient perception of health. I
know of at least 2 apps that are undergoing beta testing at
the present time.
For many patients, personalized health monitoring is
focused very much on the personal. Many patients are
interested in no more than monitoring their own symptoms.
They have no need to contextualize their experience. But
for others, the opportunity to compare their data with the
general population of patients with the same condition is an
attractive feature. And many self-monitoring apps offer the
facility to upload data to a central server.
This raises the question of data ownership. Perhaps as a
result of earlier experiences, patients can be wary about
entering large amounts of personal data into large cen-
tralized databases without concrete assurances of privacy.
This is especially applicable to chronic health conditions
such as Parkinson’s disease where details of health status
may be perceived as being of interest to insurance com-
panies for instance. Experience has taught that absolute
transparency is essential to engage patient trust. On the
whole, the database holders acknowledge individual own-
ership of individual data and ask patients for permission to
use such data in anonymized form for other purposes.
These might include the sale of de-identified data to the
pharmaceutical or insurance companies, but, more com-
monly, the data are used for research.
Returning finally to my initial theme and the suitability
of Parkinson’s disease as a test vehicle for self-monitoring,
it is apparent that the condition presents both opportunity
and challenge. The principal opportunity lies in the range
of symptoms that may/should be monitored and the many
correlations and associations with quality of life that this
engenders. For the patient who is engaged with his/her
condition, there is scope for the patient to make a tangible
contribution to shared decision making. The principal
challenge for any new app is the extent of engagement with
the Parkinson’s community. One of the less widely repor-
ted non-motor symptoms is apathy, essentially an early step
on the path to depression. Apathy can mitigate the best-
intentioned research and has strong implications for health-
related quality of life. The challenge for the most engaged
patients with Parkinson’s disease will be to communicate
that enthusiasm and engagement to those who are not
enthused or engaged. Innovations in e-health will be most
meaningful when they are universal.
Wider perspective: online social networks
and emerging technologies, Paul Wicks
In the past 5 years, a vanguard of patients with serious,
life-changing illnesses such as Jon have used technology to
connect with one another, participate in research, and better
advocate for themselves as empowered patients. But how
credible is this movement?
In the early 2000s, patients with neurological conditions
including Parkinson’s disease communicated with one
another through hosted communities such as BrainTalk,
based at Massachusetts General Hospital (MGH) [19] or
BUILD (for amyotrophic lateral sclerosis (ALS) patients)
at King’s College Hospital [20]. The advantage of having a
reputable organization like MGH or King’s involved was
that patients felt they could trust the site, clinicians would
feel comfortable referring patients there, and the insights
generated could be reflected back into the scientific liter-
ature by researchers. There were disadvantages too, how-
ever; if the site were to crash, there were no backup sites
where patients could fall back to. To maintain their repu-
tation, such communities had a strict set of policies gov-
erning patient-to-patient interactions which some felt
draconian or inhibitory to conversation. By the mid 2000’s,
advances in Internet technology meant services such as
Yahoo Groups or Ning allowed the rapid formation of new
networks that could be patient led at minimal cost and with
their own rules. However, this diffusion of expertise could
itself be a limitation; Was it better to have dozens of
fragmented online communities for people with Parkin-
son’s disease all over the web? Or did this lead to more
duplication and wasted effort?
More recently, there have been an explosion in inter-
esting online communities [21, 22], but here, we will
explore two that combine aspects of social networking
with credible scientific and quantifiable data collection;
PatientsLikeMe and 23andMe.
PatientsLikeMe was founded by a family affected by
ALS to enable patients to record their disease progression
using clinically validated outcome measures [23], share
their experiences with others at an individual [24] and
aggregate level [25], and eventually to further the course of
research by crowd-sourcing information on what works and
what does not [26]. To date, researchers on the site have
produced over thirty peer-reviewed publications: from a
clinical trial conducted over the Internet [26] to the
development of new patient-reported outcomes in ALS
[27] and multiple sclerosis [28], the detection of medica-
tion side effects and disease variability in Parkinson’s
disease [16, 29], new measures of treatment adherence
[30], and even biologically driven studies exploring the
pathogenesis of disease [31]. Clinically, the site has been
controversial because telling patients how sick they are and
198 Qual Life Res (2014) 23:195–203
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how they fit in a wider context with regard to their pro-
gression or options has traditionally been viewed as the
role of their physician. From a research perspective, the site
attracts a self-selecting and therefore somewhat biased
subset of patients whose biases vary by disease, but for
instance in the case of multiple sclerosis skew a little
younger and more likely to be female than neurological
patients seen at a specialist clinic [32].
A second innovative platform is 23andMe, an online
community that relies less on quantified self-report in
patients and more on genetic data extracted from saliva
samples collected by mail and analyzed for single nucle-
otide polymorphisms (SNPs) using regularly improving
techniques. Once the SNPs are analyzed, customers receive
access to a Web site detailing what their results mean and
providing their predicted risks of disease like Alzheimer’s
or psoriasis, as well as non-health-related tools such as
ancestry mapping. Like PatientsLikeMe, there is a forum
for discussing findings, though the sharing of data is more
carefully controlled; members of 23andMe can invite one
another to ‘‘share’’ their results, though they choose to
restrict this sharing to only a basic SNP dataset which
excludes the most serious health traits.
Although initially criticized by some bioethicists for
providing patients with ambiguous or potentially alarming
results without the support of a traditional genetic counselor,
23andMe is interesting because it disintermediates mediates
traditional barriers to letting patients try to understand their
own health risks. They too have sought to produce useful and
validated research findings to demonstrate their commitment
to science [33], presenting as many as 16 posters at the
American Society of Human Genetics meeting in 2012, for
instance (http://blog.23andme.com/23andme-research/23
andmes-presentations-at-ashg/).
It would be an understatement to say both sites have
been controversial; 23andMe in particular has provided
ample opportunity for academics to generate papers about
the potential ethical pitfalls of direct-to-consumer genetic
testing. But as they are popular with their users, continue to
operate sustainable business models, and collaborate
widely with bona fide academic institutions, they are likely
to force reconsideration of existing principles of research.
Both online platforms use PROs as a tool for self-
monitoring and research, and although these can be
developed, validated, and refined to high standards, they
remain an imperfect means of measurement. Here is where
insights from the non-medical ‘‘consumer health’’ space
are integrating into medicine. For example, if you were
trying to keep an accurate measure of your running dis-
tances and speeds, you could try and self-report how fast
you were going or time yourself with a watch. But with a
smartphone and freely available applications (‘‘apps’’) such
as Run Keeper, the data can be gather objectively and
much more accurately through embedded GPS, acceler-
ometer, and Internet connectivity. Through social portals
and connections to social networks, we can even add
motivational overlays, such as having friends give us
encouragement to be compliant to our running schedule
or congratulating us for running a personal best. What
happens when we integrate tools like this into online
medicine?
Three major trends appear tantalizing. First, sensors are
everywhere, they are getting better, and they are getting
cheaper. Earlier in the decade, the only reliable way to
capture quantitative data about walking in a disease like
Parkinson’s disease would be a complicated arrangement
such as motion capture system [34], whereas now it is
possible to use off-the-shelf technology such as an Xbox
Kinect [35], which allows home use cheaply, albeit with
reduced resolution. Looking forward, wearable computing
technologies such as Google Glass could allow for real-
time passive capture in ecologically valid situations. Glass
includes an accelerometer, GPS, still camera, video cam-
era, and connection to a smart phone—so for example, in
assessing someone with Parkinson’s disease, it should be
possible to naturalistically record instances where activities
of daily living such as making a hot drink have been
impaired by tremor. These could be archived for physician
review or even quantified to measure the effects of
treatment.
The second important trend is telemedicine through web-
enabled video cameras (‘‘webcams’’), which has the poten-
tial to broaden specialist access to a much wider pool of
patients. For example, the specialist movement disorders
team at Johns Hopkins is able to remotely care and advise
hundreds of patients with Parkinson’s disease in a nursing
home many miles away [36]. Care remains local, but
expertise is something that transmits easily. In a small ran-
domized control trial, Dorsey’s group found that telemedi-
cine visits saved the average patient 100 miles of travel and
3 h of time and 85 % of participants said they would rather
conduct further visits remotely than in person [37].
Finally the ‘‘Internet of Things’’ [38] takes these ele-
ments even further, through the use of low-cost disposable
sensors such as RFID chips which could have implications
for tracking observations of daily living (e.g. fall sensors in
clothing, usage sensors in wheelchairs, soiling sensors in
continence pads, walking sensors in shoes), connectivity
for every day objects (e.g. a car that assesses your driving
ability in real time), or specific medical applications (e.g.
medication compliance, remote calibration of a deep-brain
stimulator, interaction between food or utensils and insulin
pumps).
The exciting challenge for us in quality of life research
is to think what clarity we could bring to those aspects of
human life that remain imperceptible and personal after all
Qual Life Res (2014) 23:195–203 199
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these technologies have been brought to bear. Can we be as
rigorous about the internal world as these tools will allow
us to be about the physical one?
Integrating patient-reported outcomes in pediatric
clinical practice using a web-based tool, MA
Grootenhuis and L Haverman
In the past 10 years, there has been a growing interest in
the use of health-related quality of life (HRQOL) PROs in
clinical practice. Research in adult patients shows that the
integration of PROs in clinical practice generally improves
patient–clinician communication; PROs help in identifying
and discussing HRQOL issues and add to improvement of a
patient’s health outcomes and satisfaction with care [39,
40]. PatientViewpoint, for example, is a Web site that
collects PROs in outpatient clinical oncology and links the
data with the patient’s electronic medical record. Initial
results indicate that such a system could improve the
quality of cancer care [41]. Similarly, the use of touch-
screen completion of HRQOL with feedback to physicians
was found to improve patient–provider communication and
patient well-being [42].
Studies on the use of PROs in pediatric clinical practice
were scarce compared to adult practice [43] while there is a
particular need to address HRQOL in daily pediatric clin-
ical practice. As a result of the improvements in medical
care, the prevalence of chronic illness in children has
increased worldwide. At least 14 % of children grow up
with a chronic illness [44]. In the context of a child’s
development, the repeated measurement of HRQOL in
different developmental stages can be a valuable addition
to the clinical consultation.
In 2005, the psychosocial department of the Emma
Children Hospital started with a study on the use of PROs
in pediatrics: The Quality of Life in Childhood Oncology
(QLIC-ON) study. During the QLIC-ON study, HRQOL
questionnaires were completed at the clinic immediately
before the actual doctor’s visit, with patients using stand-
alone computers. A printed version of the PRO (so-called
PROfile) was handed to the pediatrician to be discussed
during the consultation. Engelen et al. [45] showed that
the feedback of HRQOL via PROs during the consultation
with the pediatric oncologist increased the discussion on
emotional and psychosocial functioning and improved the
identification of emotional problems in pediatric oncology
patients. In addition, the intervention did not lengthen the
duration of the consultation [46]. The method to gain the
PROs and to provide the PROfile to the pediatric oncol-
ogist was very time-consuming and often caused logistical
problems because of lack of privacy and room at the
clinic. It was concluded that the use of a web-based
program could overcome these problems and could con-
tribute to an improvement in the use of PROs in clinical
practice [47].
To study the use of electronic PROS (ePROs) in clinical
practice using a Web site, we conducted a new multicenter
study, the KLIK study (in Dutch: Kwaliteit van Leven In
Kaart, in English: Quality of Life in Clinical Practice). We
developed a Web site (http://www.hetklikt.nu), and chil-
dren between 0 and 18 years old with juvenile idiopathic
arthritis (JIA) were included. Children and/or their parents
completed the HRQOL questionnaires on the Web site at
home. The answers on the questionnaires were schemati-
cally converted into a so-called KLIK ‘‘ePROfile.’’ Pedi-
atric rheumatologists could retrieve these ePROfiles
directly from the Web site during the consultation. The
web-based ePROfile appears to be an efficient application
to systematically pay direct attention to HRQOL issues in
daily pediatric clinical practice. Our study shows that
providing information on patient’s HRQOL to the pediatric
rheumatologists leads to significantly more discussion of
emotional and social functioning during consultation and
improves the pediatric rheumatologists’ satisfaction with
the provided care. Overall, parents, children, and pediatric
rheumatologists evaluate the use of the ePROfile positively
[48].
Our hospital appeared to be ready to incorporate sys-
tematic attention for HRQOL in pediatric clinical practice
as a result of the positive findings in both adult and pedi-
atric care. Therefore, we decided to implement the use of
the KLIK ePROfile in daily clinical practice for children
with various chronic illnesses. We started with the KLIK
implementation in our hospital in June 2011, and now in
January 2013, 13 pediatric patient groups have started with
the use of KLIK in daily clinical practice. So far, more than
100 professionals followed the training course and over
1200 patients are registered on the KLIK Web site of the
Emma Children’s Hospital. Apart from PROs, we have also
added parent-reported outcomes (ParROs) to the KLIK
web portal.
Besides the implementation in our hospital, we also
started to implement KLIK in other hospitals and clinics, as
a result of collaborative projects. In the upcoming years,
we will continue to implement KLIK in more pediatric
patient groups. Pediatricians working with the KLIK
ePROfile recognize the importance of monitoring HRQOL
and tell their colleagues, which encourage others’ interest
to use KLIK in the near future. Besides including more
patient groups, we also want to start using KLIK for chil-
dren in transition to adult care. Transition of adolescents
from pediatric to adult care can be challenging [49]. As one
part of the solution, KLIK can be used as a tool to help fill
the gap between the pediatric and adult health care for
adolescents. For example, KLIK can be adapted to help to
200 Qual Life Res (2014) 23:195–203
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convey needed information between the pediatric and adult
healthcare teams during the transition process.
The implementation of the use of PROs in daily clinical
practice is a continuous process and creates new challenges
and opportunities for care, as is extensively described in
the International Society for Quality of Life Research
(ISOQOL) guidelines [50, 51]. We have described the
KLIK implementation following these methodological
recommendations composed by the International Society
for Quality of Life (ISOQOL) [52].
Conclusions and future directions
Each of the presentations in this session conveyed a comple-
mentary perspective on the use of e-health technologies and
their potential benefits and challenges. Advances in technol-
ogy are generating new opportunities to leverage e-health
tools to help individuals self-monitor and assess their symp-
toms and health, create online communities, and incorporate
the routine collection of PROs in clinical practice. The com-
mon thread across all the talks was the application of e-health
tools to empower individuals with chronic disease to be
actively engaged in the management of their health.
With the potential benefits that may be derived from
e-health technologies come potential challenges that have
likely contributed to the slow adoption of e-health in rou-
tine care. There is no one size fits all solution, and
matching the right technology for a given patient popula-
tion or desired clinical objective is key to ensuring suffi-
cient perceived usefulness and uptake. Combining different
solutions and applications such as personal health records
with home monitoring devices and sensors, and social
networking will help to tailor new technologies to indi-
viduals preferred method of managing their health. Inter-
action between broad social networking and personal
clinical care will also require a shift in the way health
professionals collaborate with patients.
Privacy data protection and ownership is a major con-
cern of any Internet-based application. The balance
between the patient as the owner of data and the medical
and academic profession’s documentation and use of the
data must be struck, with patient confidentiality always at
the forefront without impeding the development of inno-
vative solutions.
The vast amount of information online, the majority of
which is not reviewed by a credible organization, makes it
difficult for patients to effectively select information that is
valid and dismiss non-validated or potentially harmful
information. Technology that incorporates information fil-
ters and decision support can help match relevant infor-
mation to the individuals’ preferences, clinical profile, and
social and enviornmental context.
Making e-health universal, and not limiting its applica-
tion to a self-selecting demographic profile will also be
important. Equitable health care is one of the promises of
e-health, but at the same time, there is a considerable threat
that e-health may create a digital divide and deepen the gap
between the people, who do not have the skills, and access
to computers and networks, and those who do. The patient
population sub-groups who do not have the skills and
access are likely to benefit most from health technologies.
Surveys have shown that computer use is lower among
groups with lower incomes, lower education, blacks, and
those over 60 years old. Hospitals serving a greater pro-
portion of low-income patients were even less likely to
adopt electronic medical records and those without digital
systems tended to have an inferior quality of care [53].
Policy and political will be needed to ensure equitable
access for all. Early promising mechanisms have been
instigated including providing access to computers and
Internet in schools, and governments providing extra sup-
port to clinical settings in low-income areas to implement
electronic health records [53]. Ongoing implementation
and monitoring of such efforts will be important for
ensuring that countries continue to work toward equitable
access for all.
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